Pluristem therapeutics inc (PSTI)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Revenues

-

23

-

0

0

50

4

0

0

50

0

-

0

0

-

0

0

2,752

95

94

95

95

95

94

95

95

95

95

194

195

195

331

230

0

154

-

0

0

-

Cost of revenues

-

1

-

-

-

2

-

0

0

2

0

-

0

0

-

0

0

97

3

3

3

4

3

2

3

3

3

2

6

6

6

9

6

0

5

-

-

-

-

Gross profit

-

22

-

0

0

48

4

0

0

48

0

-

0

0

-

0

0

2,655

92

91

92

91

92

92

92

92

92

93

188

189

189

321

224

0

149

-

-

-

-

Research and development expenses

5,742

5,572

5,826

6,264

8,421

7,432

7,765

7,439

7,481

6,259

5,192

5,910

6,579

5,481

6,031

6,429

5,797

5,571

5,059

6,113

6,182

5,385

5,736

6,449

6,885

6,107

5,497

7,047

4,965

4,146

3,748

6,398

3,421

2

2,863

2,479

2,145

2,186

1,501

Less: participation by the Israeli Innovation Authority (IIA), Horizon 2020 and other parties

25

-

-

-

594

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: participation by the Israeli Innovation Authority (IIA), Horizon 2020 and other parties

-

932

444

-

-

1,176

1,001

1,507

1,099

621

515

1,355

242

279

1,033

2,070

41

234

931

1,950

88

506

1,699

1,985

37

1,000

2,374

-

3

-

-

-

-

-

-

-

-

-

-

Less participation by the Office of the Chief Scientist and other parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

493

1,050

-

511

1

19

27

-598

-608

-503

Research and development expenses, net

5,717

4,640

5,382

5,580

7,827

6,256

6,764

5,932

6,382

5,638

4,677

4,555

6,337

5,202

4,998

4,359

5,756

5,337

4,128

4,163

6,094

4,879

4,037

4,464

6,848

5,107

3,123

5,920

4,962

3,653

2,698

3,402

2,910

1

2,844

2,506

1,547

1,578

998

General and administrative expenses, net

1,682

-

-

-

2,473

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative expenses, net

-

1,750

1,813

-

-

2,123

2,210

2,844

2,666

2,920

2,763

2,031

1,886

1,446

1,564

1,814

1,639

1,546

1,487

1,742

1,527

1,513

1,678

2,341

2,531

1,975

1,829

1,389

1,159

1,420

1,681

3,005

1,924

1

1,637

1,331

1,152

1,246

756

Other income

-

-

-

-

-

-

-

-

-

43

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,379

-

-

-

-

-

-

-

-

Operating loss

-7,399

-6,368

-7,195

-7,931

-10,300

-8,331

-8,970

-8,776

-9,048

-8,467

-7,440

-6,586

-8,223

-6,648

-6,562

-6,173

-7,395

-4,228

-5,523

-5,814

-7,529

-6,301

-5,623

-6,713

-9,287

-6,990

-4,860

-7,216

-5,933

-4,884

-4,190

-6,086

-4,610

-2

-4,332

-3,837

-2,699

-2,824

-1,754

Financial income (expense), net

-108

-2

56

171

222

-352

184

-205

7,517

238

55

-430

359

38

238

-32

192

266

-353

519

303

56

-288

517

11

285

105

-

253

394

-

-

-

-

-

-

-

-

-

Financial income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

195

-

436

0

-161

112

86

3

65

Net loss for the period

-7,507

-6,370

-7,139

-7,760

-10,078

-8,683

-8,786

-8,981

-1,531

-8,229

-7,385

-7,016

-7,864

-6,610

-6,324

-6,205

-7,203

-3,962

-5,876

-5,295

-7,226

-6,245

-5,911

-6,196

-9,276

-6,705

-4,755

-6,990

-5,680

-4,490

-3,995

-6,125

-4,174

-1

-4,493

-3,725

-2,613

-2,821

-1,689

Basic and diluted net loss per share (in Dollars per share)

-0.42

-0.40

-0.46

-0.52

-0.86

-0.75

-0.77

-2.33

-0.01

-0.08

-0.08

-2.95

-0.09

-0.08

-0.08

-0.08

-0.09

-0.05

-0.07

-0.07

-0.10

-0.09

-0.09

-0.09

-0.14

-0.11

-0.08

-0.12

-0.10

-0.08

-0.08

-0.09

-0.09

-0.05

-0.11

-0.09

-0.07

-0.11

-0.08

Weighted average number of shares used in computing basic and diluted net loss per share (in Shares)

17,823

15,927

15,405

14,664

11,722

11,579

11,365

-270,145

110,044

105,130

97,321

-218,497

91,753

81,038

80,674

80,181

79,935

79,370

78,704

71,267

70,668

70,070

69,131

67,684

65,607

61,510

59,254

58,220

58,358

57,512

47,833

-

44,328

43,669

-

-

-

-

-

Weighted average number of shares used in computing basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,779

42,209

36,676

24,897

21,012